Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies.
Antiviral Res
; 196: 105206, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34762975
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
Spike Glycoprotein, Coronavirus
/
SARS-CoV-2
/
COVID-19
Limits:
Animals
/
Humans
Language:
En
Journal:
Antiviral Res
Year:
2021
Document type:
Article
Country of publication: